Valuation: Allied Corp.

Market Cap 1.3M 1.13M 1.06M 970K 1.83M 124M 1.85M 12.44M 4.86M 61.99M 4.9M 4.79M 205M P/E 2023
-2.13x
P/E 2024 -2.52x
Enterprise Value 7.55M 6.56M 6.11M 5.62M 10.62M 718M 10.74M 72.07M 28.17M 359M 28.36M 27.74M 1.19B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
100%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 02/05/2020
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 02/05/2020
Director/Board Member - 21/10/2024
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-5.00% - - 117
+1.85%+4.08%+61.11%-10.53% 2.34B
+2.85%+6.96%+69.71%+118.92% 1.65B
+4.17%+2.00%-44.11%+161.90% 463M
-.--%+5.66%+19.15%+12.00% 60.91M
Average +0.82%+0.25%+26.47%+70.57% 1.13B
Weighted average by Cap. +2.48%-1.31%+52.90%+54.85%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.86 0.1 0.69 0.27 3.43 0.27 0.26 11.36 0.1 0.08 0.08 0.07 0.14 9.15 0.14 0.92 0.36 4.57 0.36 0.35 15.15
Net income -10.68M -9.27M -8.64M -7.94M -15.02M -1.02B -15.18M -102M -39.83M -508M -40.09M -39.21M -1.68B -3.98M -3.45M -3.22M -2.96M -5.59M -378M -5.65M -37.95M -14.84M -189M -14.93M -14.6M -626M
Net Debt 5.65M 4.91M 4.58M 4.2M 7.95M 538M 8.04M 53.94M 21.09M 269M 21.22M 20.76M 890M 6.25M 5.42M 5.06M 4.65M 8.79M 594M 8.88M 59.63M 23.31M 297M 23.46M 22.95M 984M
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-